IBT Bioservices
IBT Bioservices社（アメリカ）は、感染症用ワクチン・医薬品開発のための様々なR&Dサービスをご提供しています。また、さまざまな新興病原体に対するモノクローナル抗体・ポリクローナル抗体・タンパク質を販売しています。本ページでは、これらの抗体とタンパク質をご紹介します。
（IBT Bioservices社のウェブサイトはこちら）
本商品は試験研究用試薬です。
体外診断薬としての利用及び人体への使用は出来ませんのでご注意下さい。
SARS-CoV-2関連商品
| 標的 | 型番 | 商品名 | 容量 | 説明書 |
|---|---|---|---|---|
| Coronavirus | 0373-001 | Rabbit anti-SARS-CoV2 RBD pAb | 100 µg | |
| Coronavirus | 0371-001 | Rabbit anti-SARS-CoV2 S1-C pAb | 100 µg | |
| Coronavirus | 0372-001 | Rabbit anti-SARS-CoV2 S1-N pAb | 100 µg | |
| Coronavirus | 0374-001 | Rabbit anti-SARS-CoV2 S2-C pAb | 100 µg | |
| Coronavirus | 0573-001 | SARS-CoV2 full-length spike protein | 100 ug | |
| Coronavirus | 0572-001 | SARS-CoV2 Nucleocapsid protein | 100 µg | |
| Coronavirus | 0571-001 | SARS-CoV2 RBD | 100 µg |
全商品リスト
| 型番 | 商品名 | 容量 | 説明書 | |
|---|---|---|---|---|
| Alpha Hemolysin (Hla) | 0221-003 | Human anti-Hla mAb (327) | 100 ug | |
| Bundibugyo Virus | 0304-001 | Rabbit anti-BDBV GP pAb | 100 ug | |
| Bundibugyo Virus | 0505-015 | Recombinant BDBV GPDTM | 100 ug | |
| C. difficile toxin A | 0250-001 | Human anti-(C. difficile toxin A) mAb | 100 ug | |
| C. difficile toxin B | 0250-002 | Human anti-(C. difficile toxin B) mAb | 100 ug | |
| C. perfringens ETX | 0240-001 | Chimeric anti-(C. perfringens ETX) mAb | 100 ug | |
| Chikungunya Virus | 01-0008 | Rabbit anti-Chikungunya (CHIKV) antiserum | 250 uL | |
| Chikungunya Virus | 04-0008 | Rabbit anti-Chikungunya (CHIKV) pAb | 500 ug | |
| Chikungunya Virus | 0306-001 | Rabbit anti-CHIKV E2 pAb | 100 ug | |
| Coronavirus | 0373-001 | Rabbit anti-SARS-CoV2 RBD pAb | 100 µg | |
| Coronavirus | 0371-001 | Rabbit anti-SARS-CoV2 S1-C pAb | 100 µg | |
| Coronavirus | 0372-001 | Rabbit anti-SARS-CoV2 S1-N pAb | 100 µg | |
| Coronavirus | 0374-001 | Rabbit anti-SARS-CoV2 S2-C pAb | 100 µg | |
| Coronavirus | 0573-001 | SARS-CoV2 full-length spike protein | 100 ug | |
| Coronavirus | 0572-001 | SARS-CoV2 Nucleocapsid protein | 100 µg | |
| Coronavirus | 0571-001 | SARS-CoV2 RBD | 100 µg | |
| Crimean-Congo Hemorrhagic Fever Virus | 04-0012 | Rabbit anti-CCHFV Gc pAb | 100 ug | |
| Crimean-Congo Hemorrhagic Fever Virus | 04-0011 | Rabbit anti-CCHFV N protein pAb | 100 ug | |
| Csa1A | 0541-002 | Conserved Staph antigen, 1A (Csa1A) 39-40 | 100 ug | |
| Csa1A | 0311-003 | Rabbit anti-Csa1A Polyclonal Antibody | 100 ug | |
| Diphtheria Toxin | 1601-001 | EcoCRM™ Diphtheria Toxin CRM197 Mutant Vaccine Carrier Protein | 1 mg | |
| Eastern Equine Encephalitis Virus | 0318-001 | Rabbit anti-EEEV E2 GP pAb | 100 ug | |
| Eastern Equine Encephalitis Virus | 0560-001 | Recombinant EEEV E2 GP (E3E2) | 100 ug | |
| Ebola Virus | 0509-001 | Ebola Virus Delta Peptide | 100 ug | |
| Ebola Virus | 0550-001 | Ebola virus-like particles (EBOV VLP) | 1 mg | |
| Ebola Virus | 0100-001 | EBOV Soluble GP (sGP) ELISA Kit | 1 ea | |
| Ebola Virus | 0260-001 | Human anti-EBOV GP mAb (KZ52) | 100 ug | |
| Ebola Virus | 0201-020 | Mouse anti-(EBOV GP) mAb (4F3) | 100 µg | |
| Ebola virus | 0201-024 | Mouse anti-EBOV GP mAb (13C6) | 100 ug | |
| Ebola Virus | 0201-016 | Mouse anti-EBOV VP40 mAb (3G5) | 100 ug | |
| Ebola Virus | 0201-017 | Mouse anti-EBOV VP40 mAb (5B12) | 100 ug | |
| Ebola Virus | 0201-018 | Mouse anti-EBOV VP40 mAb (AE11) | 100 ug | |
| Ebola Virus | 0366-001 | Rabbit anti-EBOV Delta Peptide | 100 ug | |
| Ebola Virus | 0301-015 | Rabbit anti-EBOV GP pAb | 100 ug | |
| Ebola Virus | 0301-015-bio | Rabbit anti-EBOV GP pAb Biotinylated | 100 ug | |
| Ebola virus | 0301-038 | Rabbit anti-EBOV GPddmuc pAb | 100 ug | |
| Ebola Virus | 0301-045 | Rabbit anti-EBOV L-Polymerase pAb | 500 ug | |
| Ebola Virus | 0301-012 | Rabbit anti-EBOV NP pAb | 100 ug | |
| Ebola Virus | 0365-001 | Rabbit anti-EBOV Soluble GP (sGP) pAb | 100 ug | |
| Ebola Virus | 01-0004 | Rabbit anti-EBOV VLP antiserum | 250 uL | |
| Ebola Virus | 0315-001 | Rabbit anti-EBOV VLP pAb | 500 ug | |
| Ebola virus | 0301-046 | Rabbit anti-EBOV VP24 pAb | 100 ug | |
| Ebola virus | 0301-047 | Rabbit anti-EBOV VP24 pAb | 100 ug | |
| Ebola Virus | 0301-048 | Rabbit anti-EBOV VP30 pAb | 100 ug | |
| Ebola Virus | 0301-040 | Rabbit anti-EBOV VP35 pAb | 100 ug | |
| Ebola Virus | 0301-010 | Rabbit anti-EBOV VP40 pAb | 100 ug | |
| Ebola Virus | 0511-015 | Recombinant EBOV GPddmuc (Sf9) | 100 ug | |
| Ebola Virus | 0501-001 | Recombinant EBOV GPDTM (mammalian) | 100 ug | |
| Ebola Virus | 0501-025 | Recombinant EBOV GPDTM (S2) | 100 ug | |
| Ebola Virus | 0501-026 | Recombinant EBOV GPDTM (S2) | 500 ug | |
| Ebola Virus | 0501-015 | Recombinant EBOV GPDTM (Sf9) | 100 ug | |
| Ebola Virus | 0501-016 | Recombinant EBOV GPDTM (Sf9) | 500 ug | |
| Ebola Virus | 0565-001 | Recombinant EBOV Soluble GP (sGP) | 100 ug | |
| Ebola Virus | 0501-030 | Recombinant EBOV VP24 | 100 ug | |
| Ebola Virus | 0564-001 | Recombinant EBOV VP40 | 100 ug | |
| Ebola virus | 0501-010 | Recombinant EBOV-Makona GPdTM (S2) | 100 ug | |
| Ebola virus | 0511-025 | Recombinant EBOV-Mayinga GPddmuc (S2) | 100 ug | |
| Ebola Virus | 1001-001 | Recombinant Vesicular Stomatitis Virus pseudotyped Ebola glycoprotein (rVSV pseudotyped EBOV GP) | 20 uL | |
| Ebola, Sudan, Marburg virus | 0200-003 | Pan-Filovirus Chimeric anti-GP mAb | 100 ug | |
| EsxA His6 | 0311-007 | Rabbit anti-EsxA His6 Polyclonal Antibody | 100 ug | |
| EsxA His6 | 0541-006 | S. aureus ESAT-6 secretion system extracellular protein A (EsxA His6) | 100 ug | |
| EsxB His6 | 0311-006 | Rabbit anti-EsxB His6 Polyclonal Antibody | 100 ug | |
| EsxB His6 | 0541-005 | S. aureus ESAT-6 secretion system extracellular protein B (EsxB His6) | 100 ug | |
| FhuD2 (19-302) | 0541-004 | S. aureus Ferric hydroxamate uptake D2 (FhuD2) (19-302) His6 | 100 ug | |
| FhuD2 His6 | 0311-005 | Rabbit anti-FhuD2 (19-302) His6 Polyclonal Antibody | 100 ug | |
| Hla | 0210-005 | Mouse anti-Hla mAb (6C12) | 100 ug | |
| Hla | 0210-001 | Mouse anti-Hla mAb (8B7) | 100 ug | |
| Hla | 04-0010 | Rabbit anti-Hla pAb | 500 ug | |
| Hla | 1401-002 | Recombinant Hla (tag free) | 100 ug | |
| Hld | 1401-003 | Recombinant Hld | 100 ug | |
| Hlg A | 1403-003 | Recombinant Hlg A (tag free) | 100 ug | |
| Hlg B | 0314-001 | Rabbit anti-Hlg B pAb | 500 ug | |
| Hlg B | 1404-001 | Recombinant Hlg B (tag-free) | 100 ug | |
| Hlg C | 0314-002 | Rabbit anti-Hlg C pAb | 500 ug | |
| Hlg C | 1405-001 | Recombinant Hlg C (tag-free) | 100 ug | |
| Human IgG | 0101-001 | Human IgG ELISA Kit | 1 ea | |
| Influenza Hemagglutinin H1 | 1504-001 | Recombinant Influenza hemagglutinin H1 Puerto Rico | 50 ug | |
| Influenza Hemagglutinin H10 | 1505-001 | Recombinant Influenza hemagglutinin H10 Jiangxi-Donghu | 50 ug | |
| Influenza hemagglutinin H10 | 1505-002 | Recombinant Influenza hemagglutinin H10ΔTM Jiangxi-Donghu | 100 ug | |
| Influenza Hemagglutinin H5 | 1501-001 | Recombinant Influenza Hemagglutinin H5 Vietnam | 50 ug | |
| Influenza Hemagglutinin H7 | 1502-001 | Recombinant Influenza Hemagglutinin H7 Anhui | 50 ug | |
| Influenza Hemagglutinin H9 | 1503-001 | Recombinant Influenza hemagglutinin H9 Hong Kong | 50 ug | |
| IsdB | 0541-001 | Iron-regulated surface determinant protein B (IsdB) | 100 ug | |
| IsdB | 0311-002 | Rabbit anti-IsdB peptide Polyclonal Antibody | 100 ug | |
| Japanese Encephalitis Virus | 01-0007 | Rabbit anti-Japanese Encephalitis (JEV) antiserum | 250 uL | |
| Junin Virus | 01-0006 | Rabbit anti-Junin antiserum | 250 uL | |
| Junin Virus | 04-0006 | Rabbit anti-Junin pAb | 500 ug | |
| Lassa Virus | 0307-001 | Rabbit anti-LASV GP pAb | 100 ug | |
| Lassa Virus | 0307-002 | Rabbit anti-LASV Z pAb | 100 ug | |
| Lassa Virus | 0508-001 | Recombinant Lassa Virus Z Protein | 100 ug | |
| LTA | 1600-001 | Lipoteichoic acid (LTA) | 5 mg | |
| LTA | 0270-001 | Mouse anti-LTA mAb | 200 ug | |
| LukA | 0316-001 | Rabbit anti-LukA pAb | 100 ug | |
| LukAB | 0313-001 | Rabbit anti-LukAB pAb (neutralizing) | 500 ug | |
| LukAB | 0510-001 | Recombinant LukAB (tag free) | 100 ug | |
| LukB | 0317-001 | Rabbit anti-LukB pAb | 100 ug | |
| LukD | 0530-003 | Recombinant LukD (tag free) | 100 ug | |
| LukE | 0530-004 | Recombinant LukE (tag free) | 100 ug | |
| LukF-Panton Valentine Leukocidin | 0221-004 | Human anti-LukF mab (051) | 100 ug | |
| LukF-PV | 0312-002 | Rabbit anti-LukF-PV pAb | 500 ug | |
| LukF-PV | 0536-001 | Recombinant LukF-PV (His tagged) | 100 ug | |
| LukF-PV | 0540-002 | Recombinant LukF-PV (tag free) | 100 ug | |
| LukS-Panton Valentine Leukocidin | 0221-005 | Human anti-LukS mAb (175) | 100 ug | |
| LukS-PV | 0221-001 | Mouse anti-LukS-PV mAb (1D9) | 100 ug | |
| LukS-PV | 04-0009 | Rabbit anti-LukS-PV pAb | 500 ug | |
| LukS-PV | 0530-001 | Recombinant LukS-PV (His tagged) | 100 ug | |
| LukS-PV | 0540-001 | Recombinant LukS-PV (tag free) | 100 ug | |
| Marburg virus | 0203-026 | anti-MARV GP chimeric monoclonal antibody (human IgG1) | 100 ug | |
| Marburg virus | 0203-028 | anti-MARV GP macaque-derived chimeric monoclonal antibody (human IgG1) | 100 ug | |
| Marburg Virus | 0203-027 | Chimeric anti-MARV GP mAb (2D8) | 100 ug | |
| Marburg Virus | 0203-023 | Mouse anti-MARV GP mAb (5C1) | 100 ug | |
| Marburg Virus | 0203-012 | Mouse anti-MARV VP40 mAb (1D1) | 100 ug | |
| Marburg Virus | 0203-016 | Mouse anti-MMARV VP40 mAb (6B1) | 100 ug | |
| Marburg Virus | 0566-001 | Musoke-Marburg virus-like particles (MMARV VLP) | 1 mg | |
| Marburg Virus | 0303-007 | Rabbit anti-MARV GP pAb | 100 ug | |
| Marburg Virus | 0303-007-bio | Rabbit anti-MARV GP pAb Biotinylated | 100 ug | |
| Marburg Virus | 0303-012 | Rabbit anti-MARV NP pAb | 100 ug | |
| Marburg Virus | 01-0005 | Rabbit anti-MARV VLP antiserum | 250 uL | |
| Marburg Virus | 04-0005 | Rabbit anti-MARV VLP pAb | 500 ug | |
| Marburg Virus | 0303-001 | Rabbit anti-MARV VP40 pAb | 100 ug | |
| Marburg Virus | 0516-015 | Recombinant AMARV GPddmuc (Sf9) | 100 ug | |
| Marburg Virus | 0506-015 | Recombinant AMARV GPDTM | 100 ug | |
| Marburg Virus | 0506-016 | Recombinant AMARV GPDTM | 500 ug | |
| Marburg Virus | 0568-001 | Recombinant MARV VP40 | 100 ug | |
| Marburg Virus | 0503-001 | Recombinant MMARV GPdTM | 100 ug | |
| Marburg Virus | 1004-001 | Recombinant Vesicular Stomatitis Virus pseudotyped Marburg glycoprotein (rVSV pseudotyped MARV-Angola GP) | 100 uL | |
| Nipah virus | 0580-001 | Nipah virus Attachment G protein | 100 ug | |
| PSM Alpha 3 | 1401-004 | PSM-Alpha 3 | 100 ug | |
| Rabbit anti-Rift Valley Fever (RVFV) antiserum | 01-0001 | Rabbit anti-Rift Valley Fever (RVFV) antiserum | 250 uL | |
| Ravn Virus | 0513-015 | Recombinant RAVN GPΔdmuc (S2) | 100 ug | |
| rClfA 40A | 0541-003 | S. aureus Clumping Factor A (rClfA) 40A (41-559) His6 | 100 ug | |
| rClfA 40A (41-559) | 0311-004 | Rabbit anti-rClfA 40A (41-559) His6 Polyclonal Antibody | 100 ug | |
| Reston Virus | 0305-001 | Rabbit anti-RESTV GP pAb | 100 ug | |
| Reston Virus | 0504-015 | Recombinant RESTV GPDTM | 100 ug | |
| Rift Valley Fever Virus | 04-0001 | Rabbit anti-Rift Valley Fever (RVFV) pAb | 500 ug | |
| SEA, SEB, TSST-1 | 0311-001 | Rabbit anti-(SEA, SEB, TSST-1) pAb | 500 ug | |
| SEB | 0220-013 | Mouse anti-SEB mAb (2C1) | 100 ug | |
| SEB | 0220-009 | Mouse anti-SEB mAb (3D10) | 100 ug | |
| Staphylococcal Enterotoxin K | 0532-001 | Recombinant Staphylococcal Enterotoxin K (SEK) | 100 ug | |
| Staphylococcal Enterotoxin Q | 0533-001 | Recombinant Staphylococcal Enterotoxin Q (SEQ) | 100 ug | |
| Staphylococcal Enterotoxn A | 0221-006 | Human anti-SEA mAb (514) | 100 ug | |
| Staphylococcal Enterotoxn B | 0220-014 | Anti-Staphylococcal Enterotoxin B (SEB) IgG121 mAb | 100 ug | |
| Staphylococcal Enterotoxn B | 0220-015 | Anti-Staphylococcal Enterotoxin B (SEB) IgG132AM mAb | 100 ug | |
| Staphylococcal Enterotoxn B | 0221-008 | Human anti-SEB mAb (628) | 100 ug | |
| Staphylococcal Enterotoxn B | 0221-007 | Human anti-SEB mab (930) | 100 ug | |
| Sudan Virus | 0502-001 | Recombinant SUDV GPdTM (mammalian), HA-tag | 100 ug | |
| Sudan Virus | 0502-002 | Recombinant SUDV GPdTM (mammalian), HIS-tag | 100 ug | |
| Sudan Virus | 0502-025 | Recombinant SUDV GPdTM-Gulu Strain | 100 ug | |
| Sudan Virus | 0280-001 | Mouse anti-SUDV GP mAb (16F6) | 100 ug | |
| Sudan Virus | 0202-029 | Mouse anti-SUDV GP mAb (2H5) | 100 ug | |
| Sudan Virus | 0202-018 | Mouse anti-SUDV VP40 mAb (1G10) | 100 ug | |
| Sudan Virus | 0302-020 | Rabbit anti-SUDV GP pAb | 500 ug | |
| Sudan Virus | 0302-012 | Rabbit anti-SUDV NP pAb | 100 ug | |
| Sudan Virus | 0302-030 | Rabbit anti-SUDV soluble GP (sGP) pAb | 100 ug | |
| Sudan Virus | 0302-001 | Rabbit anti-SUDV VP40 pAb | 100 ug | |
| Sudan Virus | 0512-015 | Recombinant SUDV GPddmuc (Sf9) | 100 ug | |
| Sudan Virus | 0502-015 | Recombinant SUDV GPDTM | 100 ug | |
| Sudan Virus | 0570-001 | Recombinant SUDV Soluble GP (sGP) | 100 ug | |
| Sudan Virus | 0569-001 | Recombinant SUDV VP40 | 100 ug | |
| Sudan Virus | 1002-001 | Recombinant Vesicular Stomatitis Virus pseudotyped Sudan glycoprotein (rVSV pseudotyped SUDV GP) | 40 uL | |
| Sudan Virus | 0567-001 | Sudan virus-like particles (SUDV VLP) | 1 mg | |
| Sudan Virus | 0102-001 | SUDV Soluble GP (sGP) ELISA Kit | 1 ea | |
| TSST-1 | 1402-001 | Recombinant TSST-1 (tag free) | 100 ug | |
| Vaccinia Virus | 01-0003 | Rabbit anti-Vaccinia antiserum | 250 uL | |
| Venezuelan Equine Encephalitis Virus | 01-0002 | Rabbit anti-Venezuelan Equine Encephalitis (VEE) antiserum | 250 uL | |
| Venezuelan Equine Encephalitis Virus | 04-0002 | Rabbit anti-Venezuelan Equine Encephalitis (VEE) pAb | 500 ug | |
| West Nile Viurs | 0557-001 | West Nile Virus-NS1 (S2) | 100 ug | |
| Western Equine Encephalitis Virus | 0319-001 | Rabbit anti-WEEV E2 GP pAb | 100 ug | |
| Western Equine Encephalitis Virus | 0561-001 | Recombinant WEEV E2 GP (E3E2) | 100 ug | |
| Western Equine Encephalitis Virus | 0562-001 | Recombinant WEEV E2 GP (E3E2) – (mammalian) | 100 ug | |
| Zika virus | 0308-001 | Rabbit anti-Zika GP pAb | 100 ug | |
| Zika Virus | 0308-002 | Rabbit anti-Zika NS1 pAb | 100 ug | |
| Zika Virus | 0556-002 | Recombinant Zika Ev2-dimer (S2) | 100 ug | |
| Zika Virus | 0556-001 | Recombinant Zika Ev2-monomer (S2) | 100 ug | |
| Zika Virus | 0555-001 | Recombinant Zika Ns2B-Ns3 (S2) | 100 ug |
各商品の価格のお問合せ、商品仕様書のご依頼、その他のお問い合わせは下記までお願いします。
【商品取扱元】株式会社 東京未来スタイル
info@tokyofuturestyle.com
TEL：029-851-9222 FAX：029-851-9220
